NCT02998190View on ClinicalTrials.gov

First-in-Human Single and Multiple Dose of EB8018

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

August 31, 2017

Conditions

Healthy Volunteers

Interventions

DRUG

Single Ascending Doses of EB8018

DRUG

Single Ascending Doses of placebo

DRUG

Multiple Ascending Doses of EB8018

DRUG

Multiple Ascending Doses of placebo

Trial Locations (1)

NG11 6JS

Quotient Clinical, Ruddington

Sponsors

Lead Sponsor

Collaborators (1)

Quotient Clinical

All Listed Sponsors

collaborator

Quotient Clinical

OTHER

lead

Enterome

INDUSTRY

NCT02998190 - First-in-Human Single and Multiple Dose of EB8018 | Biotech Hunter | Biotech Hunter